Each gram contains:
Erythromycin (as thiocyanate) 200 mg
3 PHARMACEUTICAL FORM
Powder for suspension
ERYMYCIN-20 WSP is indicated for the treatment of chronic respiratory disease (CRD) caused by Mycoplasma infections, and for the treatment of infectious diseases due to erythromycin sensitive bacteria such as staphylococcus aureus (infectious arthritis), Haemophilus paragalinarum (eg. Infectious coryza) and Pasteurella multocida (Pasteurellosis, pneumonia) in poultry.
Hypersensitivity to erythromycin
Concurrent administration of tetracyclines, Chloramphenicol, macrolides and Lincosamides.
4.4 Special warnings for each target species
4.9 Amounts to be administered and administration route
For oral administration.
100 g per 100 liter drinking water for 3-5 days.